These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 183194)

  • 1. Further developments in the study of 3',5' cyclic adenosine monophosphate in relation to psychiatric illness.
    Moyes IC; Moyes RB
    Postgrad Med J; 1976; 52(3 suppl):110-5. PubMed ID: 183194
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary excretion of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate.
    Murad F; Pak CY
    N Engl J Med; 1972 Jun; 286(26):1382-7. PubMed ID: 4337769
    [No Abstract]   [Full Text] [Related]  

  • 3. [Electrolyte changes and mental disorders].
    Villani F; Andreoli V; Mangoni A
    Riv Sper Freniatr Med Leg Alien Ment; 1972 Feb; 96(1):7-31. PubMed ID: 4337777
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary excretion of cyclic adenosine monophosphate in the detection and diagnosis of primary hyperparathyroidism.
    Schmidt-Gayk H; Röher HD
    Surg Gynecol Obstet; 1973 Sep; 137(3):439-44. PubMed ID: 4352824
    [No Abstract]   [Full Text] [Related]  

  • 5. Urinary excretion and circadian rhythm of cyclic-AMP and cyclic-GMP in childhood.
    Castellote MC; Barberá G; Torralba A
    Rev Esp Fisiol; 1981 Dec; 37(4):403-6. PubMed ID: 6280254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary and plasma cyclic adenosine 3',5'-monophosphate in patients with idiopathic edema.
    Kuchel O; Hamet P; Cuche JL; Tolis G; Fraysse J; Genest J
    J Clin Endocrinol Metab; 1975 Aug; 41(2):282-9. PubMed ID: 169278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of cyclic 3'5'-adenosine monophosphate excretion in parathyroid dysfunction.
    Ullrich IH; Lizarralde G
    Chronobiologia; 1977; 4(3):199-204. PubMed ID: 202439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is adenosine involved in inhibition of forskolin-stimulated cyclic AMP accumulation by caffeine in rat brain?
    Mante S; Minneman KP
    Mol Pharmacol; 1990 Nov; 38(5):652-9. PubMed ID: 2172772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diurnal urinary excretion of adenosine cyclic-3',5'-monophosphate as an indirect parameter in evaluating parathyroid function].
    Bogoniowska Z; Klimaszewski J; Kowalski A; Tylki-Szymańska A; Wieczorek E; Pronicka E
    Pediatr Pol; 1983 Apr; 58(4):313-9. PubMed ID: 6314234
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in the circadian rhythm of urinary cyclic adenosine monophosphate during the alcoholic withdrawal syndrome and related neurobiological correlations].
    Nardoni A; Di Piazza V; Marchetti E; Geatti O; Cedaro P; Lattuada L
    Minerva Med; 1985 Sep; 76(34-35):1535-40. PubMed ID: 2993962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacodynamics of depression and its relation to therapy.
    Lewis DO
    Br J Clin Pract; 1974 Jan; 28(1):21-7. PubMed ID: 4366134
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of cyclic adenosine 3',5'-monophosphate (cAMP) in urine for the diagnosis of primary hyperparathyroidism].
    Schmidt-Gayk H; Röher HD; Seyberth HW
    Chirurg; 1973 Jun; 44(6):272-4. PubMed ID: 4353321
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma and urinary cyclic AMP levels in normal and lithium-treated rats.
    Christensen S; Geisler A; Badawi I; Madsen SN
    Acta Pharmacol Toxicol (Copenh); 1977 Mar; 40(3):455-9. PubMed ID: 190862
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biological rhythm of urinary excretion of cyclic AMP in humans].
    Gennari C; Galli M; Montagnani M; D'Amore I
    Boll Soc Ital Biol Sper; 1975 Jul; 51(14):859-62. PubMed ID: 175807
    [No Abstract]   [Full Text] [Related]  

  • 15. Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration.
    Wilting I; Baumgarten R; Movig KL; van Laarhoven J; Apperloo AJ; Nolen WA; Heerdink ER; Knoers NV; Egberts AC
    Eur J Pharmacol; 2007 Jul; 566(1-3):50-7. PubMed ID: 17466972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Excretion of cyclic adenosine monophosphate in breast and lung cancer].
    Bershteĭn LM; Semiglazov VF; Baldina EA
    Vopr Onkol; 1976; 22(8):30-5. PubMed ID: 186954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALA synthetase induction. Inhibitory effect exerted by administration of dibutyryl adenosine-3',5'-cyclic monophosphate, theophylline and caffeine.
    Pinelli A; Capuano A
    Enzyme; 1973; 16(1):203-10. PubMed ID: 4364572
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical studies and applications of cyclic nucleotides.
    Murad F
    Adv Cyclic Nucleotide Res; 1973; 3():355-83. PubMed ID: 4357645
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclic AMP and neurotransmitters.
    Breckenridge BM
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():216-28. PubMed ID: 4403653
    [No Abstract]   [Full Text] [Related]  

  • 20. [Neuroendocrinological studies of mental disorders].
    Suwa N; Yamashita I
    Saishin Igaku; 1970 Oct; 25(10):2090-7. PubMed ID: 4921492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.